BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22271808)

  • 1. Diagnostic management of chronic obstructive pulmonary disease.
    Broekhuizen BD; Sachs AP; Hoes AW; Verheij TJ; Moons KG
    Neth J Med; 2012 Jan; 70(1):6-11. PubMed ID: 22271808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spirometric thresholds for diagnosing COPD: 0.70 or LLN, pre- or post-dilator values?
    Mohamed Hoesein FA; Zanen P; Sachs AP; Verheij TJ; Lammers JW; Broekhuizen BD
    COPD; 2012 Aug; 9(4):338-43. PubMed ID: 22489910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spirometry and other pulmonary function tests for the screening and evaluation of patients with chronic obstructive pulmonary disease (COPD)].
    Yoshimi K; Seyama K
    Nihon Rinsho; 2007 Apr; 65(4):664-9. PubMed ID: 17419385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.
    Papi A; Hughes R; Del Olmo R; Agusti A; Chipps BE; Make B; Tomaszewski E; Peres Da Costa K; Srivastava D; Vestbo J; Janson C; Burgel PR; Price D
    Ther Adv Respir Dis; 2024; 18():17534666241254212. PubMed ID: 38841799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
    Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
    J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease: diagnostic considerations.
    Dewar M; Curry RW
    Am Fam Physician; 2006 Feb; 73(4):669-76. PubMed ID: 16506711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
    Mohamed Hoesein FA; Zanen P; Lammers JW
    Respir Med; 2011 Jun; 105(6):907-15. PubMed ID: 21295958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lung function test for COPD].
    Itabashi S
    Nihon Rinsho; 2003 Dec; 61(12):2150-7. PubMed ID: 14674325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comments on screening spirometry for detection of COPD].
    van den Berg JW; van der Molen T; Kerstjens HA; Quanjer PH
    Ned Tijdschr Geneeskd; 2007 Jul; 151(28):1557-60. PubMed ID: 17715762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic and treatment of chronic obstructive pulmonary disease based on GOLD statement 2011].
    Barczyk A; Pierzchała W
    Pol Merkur Lekarski; 2012 Oct; 33(196):187-92. PubMed ID: 23272604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A; Melbye H
    Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical management problems of stable chronic obstructive pulmonary disease in the elderly.
    Pistelli R; Ferrara L; Misuraca C; Bustacchini S
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S43-8. PubMed ID: 22209930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
    Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA
    Respiration; 2011; 82(1):19-27. PubMed ID: 21282939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of pulmonary function in COPD.
    Cooper CB
    Semin Respir Crit Care Med; 2005 Apr; 26(2):246-52. PubMed ID: 16088441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD 'diagnosis' based on spirometric reference equations.
    Olofson J; Bake B; Tengelin MN; Houltz B
    Clin Respir J; 2008 Oct; 2(4):214-9. PubMed ID: 20298337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment.
    Allen S; Yeung P; Janczewski M; Siddique N
    Clin Respir J; 2008 Oct; 2(4):208-13. PubMed ID: 20298336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional measurements of the peripheral airways in COPD].
    Garcia G; Perez T; Verbanck S
    Rev Mal Respir; 2012 Feb; 29(2):319-27. PubMed ID: 22405121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
    Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
    Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.